The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSVE.L Regulatory News (SVE)

  • There is currently no data for SVE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

18 May 2022 14:08

RNS Number : 9817L
Starvest PLC
18 May 2022
 

18 May 2022

 

Half-year report - six months ended 31 March 2022

 

Chairman's statement

 

Over the six months to 31 March 2022, Starvest (the "Company") benefited somewhat from the resilience of the natural resources sector against a backdrop of emerging inflation and global unrest due to the conflict in eastern Europe. Nonetheless, weakness in Greatland Gold's share price resulted in a decline in portfolio value and net asset value of 17% and 16%, respectively, over the six months to 31 March 2022, since the Company's financial year-end.

 

Our discount to net asset value remained consistent over the six-month period to 31 March 2022, being 34% on 30 September 2021 and 33% on 31 March 2022, while commodity prices, including gold have in general, remained relatively high, providing a solid foundation for our investee companies.

 

While many sectors have not yet recovered to pre-pandemic levels, the natural resources sector has made significant gains and is forecast to continue to do so in an economic recovery. We also expect large-scale infrastructure and climate-focused projects, at the forefront of government spending plans, will benefit the natural resource sector.

 

As part of routine operations, the Board regularly reviews its portfolio positions and may make adjustments to its holdings to take advantage of market conditions. The Board is currently considering opportunities more likely to better align the Company's stock price with what it regards as the intrinsic value of the Company's portfolio.

 

Continuing to advance its Paterson projects, Greatland Gold (LON:GGP), which makes up over 90% of our portfolio value, estimated its Havieron project at 6.5 Moz gold equivalent in an updated JORC compliant report. Its joint venture partner Newcrest Mining is continuing with mine development and growth drilling at Havieron, while Greatland Gold concentrates on early-stage exploration targets within its other licences.

 

Ariana Resources (LON:AAU) continues to focus on exploration in south-eastern Europe with a five-year, US$2.5 million strategic alliance recently announced with Newmont Corporation through Ariana's 75%-owned West Tethyan Resources, along with gold and silver production from its mining operations in Turkey.

 

Cora Gold (LON:CORA) has completed field work on a definitive feasibility study for its flagship Sanankoro gold project, the full report is due for completion in H2 2022. Cora has also started a 7,500m drill programme to continue expansion of the resource at the Sanankoro project.

 

Kefi Minerals (LON:KEFI) continues with construction of the Tulu Kapi gold mine in Ethiopia and remains on target to start full production in 2022. Kefi has also made significant advances in its exploration and resource calculations of the Jabil Qitman and Hawiah project in Saudi Arabia.

 

Other investee companies continue their efforts as well. Oracle Power (LON:ORCP) has continued its exploration in Western Australia as well as expanding into the green energy sectors with a new hydrogen energy project in Pakistan.

 

Sunrise Resources (LON:SRES) is advancing its pozzolan-perlite project in Nevada, USA towards mine permitting, while Alba (LON:ALBA) is continuing the development of its Welsh gold deposits.

 

Despite the inevitable increase in global interest rates to stem inflationary pressures, we believe that the effects of expansionary monetary policies, continued fiscal stimulus and geopolitical tensions favour a positive outlook for gold and precious metals in the longer term.

 

 

Callum N Baxter

Chairman & Chief Executive

18 May 2022

 Statement of Comprehensive Income

 

 

6 months to 31 March 2022

6 months to 31 March 2021

Year ended

 30 September 2021

Unaudited

£

Unaudited

£

Audited

£

 

Administrative expenses

(155,472)

(147,689)

(290,993)

(Loss)/gain on disposal of financial assets

(29,383)

19,313

19,339

Movement in fair value of financial assets through profit and loss

(2,195,966)

(1,088,092)

(3,645,360)

Investment income

29,628

-

56,000

Operating profit

(2,351,193)

(1,216,468)

(3,861,014)

Interest receivable

-

-

-

Profit on ordinary activities before tax

(2,351,193)

(1,216,468)

(3,861,014)

Tax on (loss) ordinary activities

587,798

-

332,532

(Loss) attributable to equity holders of the parent

(1,763,395)

(1,216,468)

(3,528,482)

Earnings per share - see note 3

Basic

Diluted

 

(3.04 pence)

(3.04 pence)

 

(2.11 pence)

(2.11 pence)

 

(6.11 pence)

(6.11 pence)

 

Statement of Financial Position

 

 

 

6 months ended 31 March 2022

6 months ended 31 March 2021

Year ended

 30 September 2021

Unaudited

£

Unaudited

£

Audited

£

 

 

 

Non-current assets

 

 

 

 

Financial assets at fair value through profit or loss

 

11,625,035

16,596,261

14,038,887

Total non-current assets

 

11,625,035

16,596,261

14,038,887

 

 

 

Current assets

Trade and other receivables

Cash and cash equivalents

 

 

 

 

53,615

157,715

 

29,893

125,344

 

63,539

78,276

Total current assets

211,330

155,237

141,815

 

 

Current liabilities

Trade and other payables

 

(70,636)

 

(84,716)

 

(85,627)

Total current liabilities

 

(70,636)

(84,716)

(85,627)

 

 

Non-current liabilities

 

Provision for deferred tax

(1,083,288)

(2,003,618)

(1,671,086)

Total non-current liabilities

(1,083,288)

(2,003,618)

(1,671,086)

 

 

Net assets

10,682,441

14,663,164

12,423,989

 

Capital and reserves

Called up share capital

Share premium account

Retained earnings

 

 

581,144

1,868,696

8,232,601

 

 

575,740

1,779,414

12,308,010

 

 

579,820

1,848,173

9,995,996

Total equity shareholders' funds

10,682,441

14,663,164

12,423,989

 

Statement of Cash Flows

 

 

 

6 months ended 31 March 2022

6 months ended 31 March 2021

Year ended

 30 September 2021

Unaudited

£

Unaudited

£

Audited

£

 

Cash flows from operating activities

 

Operating loss

(2,351,192)

(1,216,468)

(3,861,014)

Shares issued in settlement of salaries and fees

21,847

-

72,839

Movement in fair value of investments

2,195,966

1,088,092

3,645,360

(Loss)/profit on sale of current asset investments

29,383

(19,313)

(19,339)

Decrease/(increase) in debtors

9,923

1,154

(32,493)

(Decrease) in creditors

(14,991)

(8,499)

(7,587)

Net cash used in operating activities

(109,064)

(155,034)

(202,234)

 

Cash flows from investing activities

 

Sale of current asset investments

188,503

160,013

160,145

Net cash generated from investing activities

188,503

160,013

160,145

 

Net increase in cash and cash equivalents

79,439

4,979

(42,089)

Cash and cash equivalents at beginning of period

78,276

120,365

120,365

Cash and cash equivalents at end of period

157,716

125,344

78,276

 

 

 

Statement of Changes in Equity

Share capital

Share premium

Retained earnings

Total Equity attributable to shareholders

£

£

£

£

At 30 September 2020

575,740

1,779,414

13,524,478

15,879,632

Loss for the period

-

-

(1,216,468)

(1,216,468)

Total recognised income and expenses for the period

-

-

(1,216,468)

(1,216,468)

Shares issued

-

-

-

-

Total contribution by and distributions to owners

-

-

-

-

At 31 March 2021

575,740

1,779,414

12,308,010

14,663,164

Loss for the period

-

-

(3,528,482)

(3,528,482)

Total recognised income and expenses for the period

-

-

(3,528,482)

(3,528,482)

Shares issued

4,080

68,759

-

72,839

Total contribution by and distributions to owners

4,080

68,759

-

72,839

At 30 September 2021

579,820

1,848,173

9,995,996

12,423,989

Loss for the period

-

-

(1,763,395)

(1,763,395)

Total recognised income and expenses for the period

-

-

(1,763,395)

(1,763,395)

Shares issued

1,324

20,523

-

21,847

Total contributions by and distributions to owners

1,324

20,523

-

21,847

At 31 March 2022

581,144

1,868,696

8,232,601

10,682,441

 

Interim report notes

 

1. Interim report

The information relating to the six-month periods to 31 March 2022 and 31 March 2021 is unaudited. 

The information relating to the year ended 30 September 2021 is extracted from the audited accounts of the Company which have been filed at Companies House and on which the auditors issued an unqualified audit report.

2. Basis of preparation

This report has been prepared in accordance with applicable United Kingdom accounting standards, including Financial Reporting Standard 102 - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' ('FRS102'), and with the Companies Act 2006. Although the information included herein does not constitute statutory accounts within the meaning of section 435 of the Companies Act 2006, the accounting policies that have been applied are consistent with those adopted for the statutory accounts for the year ended 30 September 2021.

The Company will report again for the full year to 30 September 2022.

The Company's investments at 31 March 2022 are stated at the current market value based on market quoted prices at the close of business on 31 March 2022. The Chairman's statement includes a valuation based on market quoted prices at the close of business on 31 March 2022.

3. Earnings per share

 

 

6 months ended 31 March 2022

6 months ended 31 March 2021

Year ended

 30 September 2021

Unaudited

£

Unaudited

£

Audited

£

 

Loss for the year:

(1,763,395)

(1,216,468)

(3,528,482)

 

Weighted average number of Ordinary shares of £0.01 in issue

 

58,080,245

 

57,573,986

 

57,755,713

 

Earnings per share - basic and diluted

 

(3.04 pence)

 

(2.11 pence)

 

(6.11 pence)

 

Investment portfolio

Starvest now holds trade investments in the companies listed below; of these the following companies comprised 99% of the portfolio value as at 31 March 2022:

 

· Alba Mineral Resources plc

Exploration for oil in England, lead-zinc in Ireland, uranium in Mauritania and graphite in Greenland

www.albamineralresources.com

 

· Ariana Resources plc

Gold-silver production and exploration in Turkey, and precious metal exploration in Eastern Europe

www.arianaresources.com

· Cora Gold Limited

Gold exploration in West Africa

www.coragold.com

 

· Greatland Gold plc

Gold exploration and development in Australia

www.greatlandgold.com

· Kefi Minerals plc

Gold and copper exploration and development in Ethiopia and Saudi Arabia

www.kefi-minerals.com

· iOracle Power plc

Coal development in Pakistan and gold exploration in Australia

www.oraclepower.co.uk

Other direct and indirect mineral exploration companies:

 

· Block Energy plc (formerly Goldcrest Resources plc)

Oil and gas exploration in Bulgaria

www.blockenergy.co.uk

· Sunrise Resources plc

Exploration for industrial minerals in United States, Finland, Australia and Ireland

www.sunriseresourcesplc.com

 

Other investee companies are listed in the Company's 2021 annual report available on request or from the Company web site - www.starvest.co.uk

Copies of this interim report are available free of charge by application in writing to the Company Secretary at the Company's registered office, Salisbury House, London Wall, London EC2M 5PS, by email to info@starvest.co.uk or from the Company's website - www.starvest.co.uk

 

Enquiries to:

Starvest PLC

Callum Baxter or Gemma Cryan 02077 696 876 or info@starvest.co.uk

Grant Thornton UK LLP (Nomad)

Colin Aaronson, Harrison Clarke or Ciara Donnelly 02073 835 100

SI Capital Ltd (Broker)

Nick Emerson or Alan Gunn 01483 413 500

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR GPUCUAUPPGWR
Date   Source Headline
29th Nov 20237:00 amRNSCancellation - STARVEST Plc
28th Nov 20237:00 amRNSUpdate on Second General Meeting
23rd Nov 20235:45 pmRNSStarvest
21st Nov 202312:39 pmRNSResult of General Meeting
27th Oct 20237:00 amRNSProposed AIM Cancellation and Notice of GM
9th Oct 20233:43 pmRNSHolding(s) in Company
2nd Oct 20233:07 pmRNSNet Asset Value at 30 September 2023
4th Jul 20237:00 amRNSNet Asset Value(s)
6th Jun 20237:00 amRNSHalf-year Report
13th Apr 20234:32 pmRNSDirector/PDMR Shareholding
3rd Apr 20232:24 pmRNSNet Asset Value at 31 March 2023
21st Mar 202312:17 pmRNSResult of AGM
21st Mar 20237:00 amRNSNet Asset Value at 17 March 2023
8th Feb 20237:00 amRNSNotice of AGM
7th Feb 202312:10 pmRNSFinal Results
3rd Jan 20232:02 pmRNSNet Asset Value(s)
7th Dec 20227:00 amRNSHolding(s) in Company
3rd Oct 20223:02 pmRNSNet Asset Value at 30 September 2022
1st Sep 20227:00 amRNSDirectorate Change
5th Jul 20227:00 amRNSNet Asset Value at 30 June 2022
22nd Jun 202210:43 amRNSHolding(s) in Company
18th May 20222:08 pmRNSHalf-year Report
29th Apr 20227:00 amRNSTotal Voting Rights
19th Apr 20224:40 pmRNSSecond Price Monitoring Extn
19th Apr 20224:35 pmRNSPrice Monitoring Extension
12th Apr 20225:56 pmRNSDirector Dealings Replacement
12th Apr 202211:07 amRNSDirectors Dealings
7th Apr 202211:54 amRNSIssue of Equity, TVR and Directors' Holdings
5th Apr 202210:38 amRNSNet Asset Value at 31 March 2022
22nd Mar 202211:33 amRNSResult of AGM
22nd Mar 20229:02 amRNSNet Asset Value at 21 March 2022
15th Feb 20223:35 pmRNSNotice of AGM
15th Feb 202211:48 amRNSAudited results for the year end 30 September 2021
21st Jan 202211:04 amRNSHolding(s) in Company
4th Jan 20222:20 pmRNSNet Asset Value at 31 December 2021
1st Dec 202110:18 amRNSTotal Voting Rights
16th Nov 202110:54 amRNSIssue of Shares to Directors. Total Voting Rights
4th Oct 20211:27 pmRNSNet Asset Value at 30 September 2021
30th Jul 20217:00 amRNSTotal Voting Rights
27th Jul 202111:00 amRNSIssue of Shares to Directors. Total Voting Rights
1st Jul 202112:15 pmRNSNet Asset Value
30th Jun 20217:00 amRNSTotal Voting Rights
2nd Jun 20212:30 pmRNSIssue of Shares to Directors. Total Voting Rights
26th May 20219:31 amRNSHalf-year Report
6th Apr 20219:48 amRNSNet Asset Value(s)
17th Mar 20215:00 pmRNSDirector Shareholding Notification
16th Mar 20211:20 pmRNSResult of AGM
11th Feb 202112:09 pmRNSNotice of AGM
10th Feb 20217:00 amRNSAudited results for the year end 30 September 2020
20th Jan 202112:50 pmRNSShare Price Movement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.